|
|
|
| Clinical application of Phloroglucinolin in the process of terminating midtrimester pregnancy in scar uterus |
| REN Hongwei1 WANG Yan1 ZHANG Yuxiang1 ZHAO Yuan2 DOU Weina2 XING Jingna1 DING Ya1 HAN Wenfeng3 |
1.Department of Gynecology, the Seventh People′s Hospital of Hebei Province, Hebei Province, Dingzhou 073000, China;
2.Department of Obstetrics, the Seventh People′s Hospital of Hebei Province, Hebei Province, Dingzhou 073000, China;
3.Department of Oncology, the Seventh People′s Hospital of Hebei Province, Hebei Province, Dingzhou 073000, China |
|
|
|
Abstract objective To observe the clinical efficacy and safety of Phloroglucinol in the process of terminating midtrimester pregnancy in scar uterus. Methods From January 2017 to June 2019, a total of 78 cases with scar uterus who desiring to terminate midtrimesting pregnancy were selected from the Seventh People′s Hospital of Hebei Province. They were divided into observation group and control group according to the random number table method, with 39 cases in each group. In observation group, Mifepristone combined with Misoprostol were used to induce labor, and 5% glucose 250 mL plus Resorcinol 160 mg was given by intravenous infusion when the uterine orifice was 1 cm. Control group was induced by Mifepristone combined with Misoprostol. The time of induced labor, the degree of patiens pain, the laceration of soft birth canal, the success rate of terminating pregnancy, the bleeding of induced labor, and the adverse reactions were observed and recorded. Results The time of induced labor in observation group was shorter than that of control group , the degree of patiens pain was less severe than that of control group, the proportion of patients with soft birth canal laceration was lower than that of control group, the success rate of labor induction was higher than that of control group, and the differences were statistically significant (all P < 0.05). There was no statistically significant difference between the two groups in the bleeding of induced labor and the incidence of adverse reactions (P > 0.05). Conclusion When Mifepristone combined with Misoprostol are used to induce labor in terminating midtrimester pregnancy in scar uterus, the addition of Phloroglucinol is safe and effective, and can improve the success rate of labor induction, shorten labor induction time, reduce the pain of patients, and not increase the amount of blood loss, which is worthy of clinical application.
|
|
|
|
|
|
[1] 李彩云，李静.米非司酮联合依沙吖啶治疗瘢痕子宫中期妊娠引产临床观察[J].临床医药文献电子杂志，2018， 5（37）：153-154.
[2] 张丽.米非司酮联合依沙吖啶治疗瘢痕子宫中期妊娠引产临床效果分析[J].中外女性健康研究，2019（5）：70， 121.
[3] 丁远芹.米索前列醇联合米非司酮对瘢痕妊娠中期孕妇进行引产的效果评价[J].当代医药论丛，2018，16（13）：70-72.
[4] 张小兰.用利凡诺联合米非司酮对瘢痕子宫再次妊娠的孕中期孕妇进行引产的效果评价[J].当代医药论丛，2019，17（10）：143-144.
[5] 翁俊英.米非司酮口服联合乳酸依沙吖啶注射液羊膜腔内注射在瘢痕子宫中期妊娠引产中的应用[J].河南医学研究，2019，28（10）：1830-1831.
[6] 刘俊杰，赵俊.现代麻醉学[M].2版.北京：人民出版社，1998.
[7] 谢幸，孔北华，段涛.妇产科学[M].9版.北京：人民卫生出版社，2018.
[8] 张宪华.戊酸雌二醇联合米非司酮在妊娠中期行引产治疗的效果观察[J].中国现代药物应用，2018，12（4）：122-123.
[9] 王敏，薛惠英.依沙吖啶联合米非司酮和米索前列醇治疗中期妊娠引产的疗效观察[J].现代药物与临床，2018， 33（2）：325-329.
[10] 李景霞.米非司酮联合乳酸依沙吖啶注射液经腹羊膜腔内注射在瘢痕子宫中期妊娠引产中的应用观察[J].现代诊断与治疗，2018，29（10）：1575-1577.
[11] 刘顺华，刘佳晔.米非司酮联合米索前列醇与羊膜腔外注射依沙丫啶在特殊妊娠中期引产中的疗效比较[J].中国妇幼保健，2018，33（4）：868-872.
[12] 杜文渊，于晓霞，王小莎，等.乳酸依沙吖啶联合子宫颈扩张单球囊对瘢痕子宫中期妊娠引产的应用效果[J].现代生物医学进展，2018，18（3）：524-527.
[13] 王娟，李洁，刘虹.米非司酮口服联合依沙吖啶羊膜腔注射对瘢痕子宫中期妊娠的引产效果及安全性评价[J].中国药业，2018，27（6）：45-47.
[14] 彭茂兰，涂建军.米非司酮联合米索前列醇片应用于50例瘢痕子宫中期妊娠引产的效果[J].当代医学，2019， 25（13）：138-139.
[15] 张花蕊.Foley′s导尿管联合米索前列醇在瘢痕子宫中期妊娠患者引产中的应用效果[J].河南医学研究，2019， 28（2）：263-264.
[16] 李忠辉，刘江美，赖竹圆.单纯依沙吖啶和米非司酮分别配伍米索前列醇、依沙吖啶在中期引产中的效果对比[J].中国当代医药，2018，25（8）：74-76.
[17] 李娟.米非司酮配伍米索前列醇在中期妊娠引产孕妇中的应用价值[J].医疗装备，2019，32（14）：110-111.
[18] 王姿斌，马鲁杭，瞿微微，等.间苯三酚联合催产素对计划分娩初产妇引产效果观察[J].浙江医学，2019，41（8）：829-831.
[19] 成芳娣.间苯三酚结合缩宫素对足月妊娠的引产效果及安全性分析[J].中国医药指南，2016，14（22）：109.
[20] CAHEN R. Phloroglucionol：a pharmacological reevaluation.I.Smooth muscle relaxing properties [J]. Arch Int Pharmacodyn Ther，1962，138：311-319.
[21] 张凡，杨菁.米非司酮联合间苯三酚在中孕引产中的临床疗效观察[J].中国性科学，2017，26（9）：119-121.
[22] 傅小青，孙健.间苯三酚注射液对产程活跃期宫颈水肿产妇的临床效果分析[J].中国现代医生，2018，56（29）：68-70.
[23] 何倩影.间苯三酚加速产程的效果及对妊娠结局的影响观察[J].中国医药科学，2018，8（18）：79-81.
[24] 韩敏.米非司酮联合米索前列醇序贯疗法用于中期妊娠引产疗效观察[J].航空航天医学杂志，2013，24（1）：70-71.
[25] 侯亚梅.依沙吖啶羊膜腔外注射联合间苯三酚在妊娠中期引产中的效果观察[J].河北医科大学学报，2016， 37（1）：86-88.
[26] 冷颖，谭瑛.间苯三酚在绝经后取环术中应用的临床观察[J].临床合理用药杂志，2015，8（34）：89-90.
[27] 李玲，曾凡慧，郭冠荣.间苯三酚用于终止中期妊娠羊水过少10例临床分析[J].大家健康：学术版，2012，6（11）：69-70. |
|
|
|
